This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Aspergillus oryzae is an extract from Aspergillus oryzae used in allergy testing.

Generic Name
Aspergillus oryzae
DrugBank Accession Number
DB10448
Background

Aspergillus oryzae allergenic extract is used in allergenic testing.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
  • Aspergillus flavus var. oryzae
  • Aspergillus flavus var. oryzae whole
  • Aspergillus oryzae
  • Eurotium oryzae

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Dairy Digestive Ultra Strength SupplementTablet9000 unitOralVita Health Products Inc2004-04-012007-07-30Canada flag
Lactozyme - CapCapsule3000 unit / capOralJamieson Laboratories Ltd1995-12-312004-07-01Canada flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Fapp MixtureAspergillus oryzae (20000 [PNU]/1mL) + Aspergillus niger var. niger (20000 [PNU]/1mL) + Aspergillus repens (20000 [PNU]/1mL) + Aspergillus terreus (20000 [PNU]/1mL) + Fusarium graminearum (20000 [PNU]/1mL) + Penicillium chrysogenum var. chrysogenum (20000 [PNU]/1mL) + Phoma exigua var. exigua (20000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Mixed AspergillusAspergillus oryzae (10000 [PNU]/1mL) + Aspergillus niger var. niger (10000 [PNU]/1mL) + Aspergillus repens (10000 [PNU]/1mL) + Aspergillus terreus (10000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1998-02-23Not applicableUS flag
Mixed AspergillusAspergillus oryzae (10000 [PNU]/1mL) + Aspergillus niger var. niger (10000 [PNU]/1mL) + Aspergillus repens (10000 [PNU]/1mL) + Aspergillus terreus (10000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1998-02-23Not applicableUS flag
Mixed AspergillusAspergillus oryzae (40000 [PNU]/1mL) + Aspergillus niger var. niger (40000 [PNU]/1mL) + Aspergillus repens (40000 [PNU]/1mL) + Aspergillus terreus (40000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Mixed AspergillusAspergillus oryzae (20000 [PNU]/1mL) + Aspergillus niger var. niger (20000 [PNU]/1mL) + Aspergillus repens (20000 [PNU]/1mL) + Aspergillus terreus (20000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Mixed AspergillusAspergillus oryzae (0.05 g/1mL) + Aspergillus niger var. niger (0.05 g/1mL) + Aspergillus repens (0.05 g/1mL) + Aspergillus terreus (0.05 g/1mL)Injection, solutionPercutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Mixed AspergillusAspergillus oryzae (20000 [PNU]/1mL) + Aspergillus niger var. niger (20000 [PNU]/1mL) + Aspergillus repens (20000 [PNU]/1mL) + Aspergillus terreus (20000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Mixed MoldsAspergillus oryzae (10000 [PNU]/1mL) + Alternaria alternata (10000 [PNU]/1mL) + Aspergillus niger var. niger (10000 [PNU]/1mL) + Aspergillus repens (10000 [PNU]/1mL) + Aspergillus terreus (10000 [PNU]/1mL) + Cladosporium sphaerospermum (10000 [PNU]/1mL) + Penicillium chrysogenum var. chrysogenum (10000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Mixed MoldsAspergillus oryzae (40000 [PNU]/1mL) + Alternaria alternata (40000 [PNU]/1mL) + Aspergillus niger var. niger (40000 [PNU]/1mL) + Aspergillus repens (40000 [PNU]/1mL) + Aspergillus terreus (40000 [PNU]/1mL) + Cladosporium sphaerospermum (40000 [PNU]/1mL) + Penicillium chrysogenum var. chrysogenum (40000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Mixed MoldsAspergillus oryzae (10000 [PNU]/1mL) + Alternaria alternata (10000 [PNU]/1mL) + Aspergillus niger var. niger (10000 [PNU]/1mL) + Aspergillus repens (10000 [PNU]/1mL) + Aspergillus terreus (10000 [PNU]/1mL) + Cladosporium sphaerospermum (10000 [PNU]/1mL) + Penicillium chrysogenum var. chrysogenum (10000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1998-02-23Not applicableUS flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
Q6Z8UK5R3G
CAS number
Not Available

References

General References
Not Available
RxNav
1329940
Wikipedia
Aspergillus_oryzae

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
TabletOral9000 unit
CapsuleOral3000 unit / cap
Injection, solutionPercutaneous
Injection, solutionSubcutaneous
TabletOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53